Introduction

 

Testicular cancer is the most common form of cancer in males between the ages of 15 and 35. However, it accounts for only 1 percent of all cancers in men. An estimated 8,090 men will be diagnosed with testicular cancer in 2008, according to the American Cancer Society.

The testicles are the male reproductive organs that produce sperm and male hormones. Sperm is produced by adult males as an essential part of reproduction. Male hormones control the development of the reproductive organs, as well as other male characteristics, such as body and facial hair, deep voice, and wide shoulders. The testicles, which are also called testes, are located behind the penis in a pouch of skin called the scrotum.

Cancer that develops within one or both testicles is called testicular cancer. It is one of the most curable forms of cancer. Other names for cancer of the testicles are cancer of the testes, testes cancer, or testis cancer. (The plural of "testis" is "testes." Most men have one testis on each side, or two testes total.)

The exact cause of testicular cancer is not known. One of the major risk factors for testicular cancer is cryptorchidism, a condition in which one or both of the testicles have not descended into the scrotum. Normally, testicular descent occurs before birth. Other risk factors include Kleinfelter's syndrome (an inherited disorder), a family history of testicular cancer, infection with the human immunodeficiency virus (HIV), and exposure before birth to the hormone diethylstilbestrol (DES), which in the past was sometimes prescribed to pregnant women.

This content was last modified on April 23, 2008 .
Latest Urology News
Prostate cancer radiotherapy safe for HIV patients

December 1, 2008 — NEW YORK (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men. Treatment appears to have no long-term effect on CD4+ cell count or viral load.

Drug proves useful in hard-to-treat BPH: study

November 28, 2008 — NEW YORK (Reuters Health) - In men with an enlarged prostate who fail to respond to tamsulosin (brand name Flomax), treatment with the drug naftopidil may help alleviate common bothersome symptoms, such as having to make frequent nightly trips to the bathroom to urinate, research shows.

Cancer rates and cancer-related deaths drop in U.S.

November 25, 2008 — NEW YORK (Reuters Health) - For the first time ever, the overall cancer incidence and death rates have declined for men and women in the United States, according to an annual report released Tuesday by the American Cancer Society, the National Cancer Institute, and other groups.

Select news items provided by Reuters Health